Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
Clinical trial NCT05714514 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05714514
- Sponsor
- Hansa Biopharma AB
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-21
- Primary completion
- 2027-12-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.